Stratum Biosciences
PrivateLast Round
Seed
Mar 27, 2026
Total Funding Raised
$2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Stratum Biosciences operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in March 2026.
Stratum Biosciences is a biotechnology company that operates an AI-powered skin biology discovery platform to develop novel active ingredients and formulations for cosmetic and pharmaceutical skin products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Fashion & Beauty, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stratum Biosciences Comparables
Compare Stratum Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Outer Biosciences | 87% | |
| Debut | 77% | |
| BELANO medical AG | 63% |
For institutional investors. Book with your work email.
Stratum Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Stratum Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Harvard Business School Alumni Angels of Greater New York | Seed |
| Johnson & Johnson Innovation - JLABS | Seed |
| Nvidia Inception | Seed |
| Skin Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 39% MoM.
- Apr 27, 2026
Grew 63% QoQ, from 8 to 13 employees.
For institutional investors. Book with your work email.
Stratum Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Stratum Biosciences's valuation, stock price, and market status.
Is Stratum Biosciences a public or private company?
Stratum Biosciences is a private company.
What is the current stock price of Stratum Biosciences?
Stratum Biosciences is a private company, so its shares have no public market price. Caplight tracks Stratum Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Stratum Biosciences worth (valuation)?
Valuation information for Stratum Biosciences is not publicly available.
Can I buy Stratum Biosciences stock?
Stratum Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Stratum Biosciences's last funding round?
Stratum Biosciences's most recent funding round was Seed on March 27, 2026.
Who are the main investors in Stratum Biosciences?
Key investors in Stratum Biosciences include Harvard Business School Alumni Angels of Greater New York, Johnson & Johnson Innovation - JLABS, Nvidia Inception, Skin Angels.
Will Stratum Biosciences IPO soon?
No public IPO plans have been announced for Stratum Biosciences.
How can I track Stratum Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Stratum Biosciences's shares on secondary markets.